Christina Schwarz is a pharmaceutical and biotechnology patent litigator who focuses on complex litigation and contested proceedings. Christina has argued before the federal district courts, the U.S. Court of Appeals for the Federal Circuit, and the Patent Trial and Appeal Board (PTAB).
She also frequently counsels clients on litigation and non-litigation matters, and conducts pre-lawsuit investigations. Her work covers a wide range of products and technologies, including drugs and treatments for numerous cancers and non-malignant tumors, immunosuppression, HCV, renal disease, Pompe disease, schizophrenia, drug formulations, drug delivery devices, and polymers.
Experience :
- Represented Novartis in Novartis v. Breckenridge, West-Ward and Par (Zortress® (everolimus) for kidney and liver transplants) (D. Del., Fed. Cir., PTAB-IPR)
- Represented Novartis in Novartis v. West-Ward (Afinitor® (everolimus) for renal cell carcinoma and pancreatic neuroendocrine tumors) (D. Del., Fed. Cir., PTAB-IPR)
- Represented Novartis in Novartis v. Breckenridge (Afinitor® (everolimus) for renal cell carcinoma, renal angiomyolipoma, and tuberous sclerosis complex with subependymal giant cell astrocytoma) (D. Del., PTAB-IPR)
- Represented Novartis in Novartis v. Mylan (Afinitor® Disperz (everolimus) for tuberous sclerosis complex with subependymal giant cell astrocytoma) (D. Del.)
Education :
- J.D. University of Western Ontario 2007
- M.Sc. University of Toronto 2004
- B.Sc. University of Toronto 2002
Bar Admissions : New York, Ontario, Canada
Court Admissions :
- U.S. Court of Appeals for the Federal Circuit
- U.S. District Court for the Eastern District of New York
- U.S. District Court for the Southern District of New York
